A1C is one of the most useful tools in diabetes care, but it has an important limitation: it takes time to reflect change. Could a faster-moving marker help clinicians know sooner whether treatment is working? New randomized research on glycated albumin in diabetes offers an intriguing answer. Glycated albumin reflects …
Read More »A Positive Type 1 Diabetes Screen Isn’t Always Equal: Why IA-2 Changes the Risk Calculation
As population-based screening for type 1 diabetes (T1D) becomes more common, clinicians increasingly encounter positive islet autoantibody results in children and adults who have no symptoms. However, not all positive screening results carry the same clinical significance. A single positive autoantibody may indicate elevated risk, yet the specific antibody detected …
Read More »Post-Meal Blood Sugar Spikes: Are We Focusing on the Wrong Diabetes Numbers?
For decades, A1C has served as the cornerstone of diabetes management. It remains an essential marker because it reflects average blood glucose levels over approximately three months. However, many clinicians are recognizing that managing post-meal glucose levels may provide equally important insights into a patient’s metabolic health. A person can …
Read More »GLP-1 Therapy and Diagnostic Drift: Are We Masking Disease Progression?
Disease progression in patients using GLP-1 therapies is becoming a critical topic as these medications continue to reshape diabetes care. While GLP-1 receptor agonists improve glycemic control and support weight loss, could they also be hiding deeper metabolic decline? Much like a polished surface that conceals underlying cracks, improved lab …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.